Company / Cost of Revenue
VIEMED HEALTHCARE, INC. Cost of Revenue History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$70.2M
FY2025
5-year range
$43.7M / $70.2M
FY2021-FY2025
Trend
+29.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $54M to $70M over the past 2 years.
Based on SEC 10-K filings.
$70M in FY2025 with a 5-year CAGR of +23.7%.
Increased from $54M to $70M over the past 2 years.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +17.2%
- 5-Year CAGR
- +23.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +23.7%, indicating consistent growth.
- In FY2025, cost of revenue increased 29.7% year-over-year.
- Lowest cost of revenue in the period was in FY2019.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $70.2M | +29.7% |
| FY2024 | $54.2M | +0.0% |
| FY2023 | $54.2M | +24.1% |
| FY2022 | $43.7M | -14.7% |
| FY2021 | $51.2M | +111.1% |
| FY2020 | $24.3M | +45.3% |
| FY2019 | $16.7M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026